切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2026, Vol. 23 ›› Issue (01) : 83 -87. doi: 10.3877/cma.j.issn.1672-6448.2026.01.012

综述

超声定量评估儿童代谢相关脂肪性肝病的研究进展
田宇蒙, 杨莉(), 孙笑   
  1. 028000 通辽市人民医院超声医学科
  • 收稿日期:2025-05-01 出版日期:2026-01-01
  • 通信作者: 杨莉
  • 基金资助:
    内蒙古医学科学院公立医院科研联合基金项目(2024GLLH0913)

Advances in quantitative ultrasound assessment of pediatric metabolic-associated fatty liver disease

Yumeng Tian, Li Yang(), Xiao Sun   

  • Received:2025-05-01 Published:2026-01-01
  • Corresponding author: Li Yang
引用本文:

田宇蒙, 杨莉, 孙笑. 超声定量评估儿童代谢相关脂肪性肝病的研究进展[J/OL]. 中华医学超声杂志(电子版), 2026, 23(01): 83-87.

Yumeng Tian, Li Yang, Xiao Sun. Advances in quantitative ultrasound assessment of pediatric metabolic-associated fatty liver disease[J/OL]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2026, 23(01): 83-87.

1
中华医学会儿科学分会消化学组,中国儿童慢性肝病协作组,中华儿科杂志编辑委员会.儿童代谢功能障碍相关脂肪性肝病诊治专家共识(2025)[J].中华儿科杂志, 2025, 63(9): 960-966.
2
Mohammed E, Naim A, Pietro V, et al. Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement[J]. Lancet Gastroenterol Hepatol, 2021, 6(10): 864-873.
3
Omaña-Guzmán I, Rosas-Diaz M, Martínez-López YE, et al. Strategic interventions in clinical randomized trials for metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity in the pediatric population: a systematic review with meta-analysis and bibliometric analysis[J]. BMC Med, 2024, 22(1): 548.
4
戴文, 姚珍珍, 欧阳思思, 等. 超重/肥胖儿童非酒精性脂肪肝病患病率及其影响因素的横断面研究[J]. 中国当代儿科杂志, 2023, 25(5): 448-456.
5
李玮. 儿童代谢相关性脂肪肝的临床特点及长期预后的队列研究[D].广州: 南方医科大学, 2023.
6
吴霞, 王训, 谭燕, 等. 超声定量肝肾指数用于诊断儿童非酒精性脂肪性肝病[J].中国介入影像与治疗学, 2024, 21(2): 89-93.
7
Wu H, Zeng Y, Chen F, et al. The diagnostic value of ultrasound-guided attenuation parameter (UGAP) in metabolic fatty liver disease[J]. Curr Med Imaging, 2024, 20: e15734056275504.
8
罗洪霞, 李静秋, 李媛媛, 等. 超重/肥胖非酒精性脂肪性肝病儿童磁共振质子密度脂肪分数检测意义研究[J]. 实用肝脏病杂志, 2024, 27(4): 527-530.
9
Dillman JR, Trout AT, Costello EN, et al. Quantitative liver MRI-Biopsy correlation in pediatric and young adult patients with nonalcoholic fatty liver disease: can one be used to predict the other?[J]. AJR Am J Roentgenol, 2018, 210(1): 166-174.
10
Ezenwuba BN, Hynes CM. Ultrasound screening of paediatric non-alcoholic fatty liver disease (MAFLD): A critical literature review[J]. Radiography(Lond), 2024, 30(5): 1317-1325.
11
Wasilewska N, Bobrus-Chociej A, Narasim-Symbor E, et al. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease[J]. Lipids Health Dis, 2018, 17(1): 216.
12
党英楠, 高瑞阳, 宾光宇, 等. 超声背散射统计参数成像评价儿童脂肪肝的新方法[J]. 中国医疗设备, 2023, 38(9): 17-24.
13
Erdem Toslak I, Lim-Dunham JE, Joyce C, et al. A practical approach to quantitative grayscale ultrasound analysis of hepatic steatosis in pediatric patients using a picture archiving and communication system-based tool[J]. J Ultrasound Med, 2018, 37(10): 2395-2403.
14
D'Hondt A, Rubesova E, Xie H, et al. Liver fat quantification by ultrasound in children: a prospective study[J]. AJR Am J Roentgenol, 2021, 217(4): 996-1006.
15
Frankland MP, Dillman JR, Anton CG, et al. Diagnostic performance of ultrasound hepatorenal index for the diagnosis of hepatic steatosis in children[J]. Pediatr Radiol, 2022, 52(7): 1306-1313.
16
Hajibonabi F, Riedesel EL, Taylor SD, et al. Ultrasound-estimated hepatorenal index: diagnostic performance and interobserver agreement for pediatric liver fat quantification[J]. Pediatr Radiol, 2024, 54(10): 1653-1660.
17
Jia S, Zhou J, Zhang Q, et al. Clinical research of fibroscan-TE-CAP at noninvasive diagnosis of hepatic steatosis in children[J].Clinics(Sao Paulo), 2024, 79: 100387.
18
程丹颖, 李贲, 纪世博, 等. 瞬时弹性成像技术在肝纤维化无创诊断中的应用[J/CD]. 中国肝脏病杂志(电子版), 2021, 13(4): 9-13.
19
David P, Valentin B, Newsome PN, et al. Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient dameta-analysis[J]. Lancet Gastroenterol Hepatol, 2021, 6(3): 185-198.
20
Desai NK, Harney S, Raza R, et al. Comparison of controlled attenuation parameter and liver biopsy to assess hepatic steatosis in pediatric patients[J]. J Pediatr, 2016, 173: 160-164.e1.
21
Shin J, Kim MJ, Shin HJ, et al. Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard[J]. BMC Pediatr, 2019, 19(1): 112.
22
Anand A, Shalimar, Jana M, et al. Usefulness of controlled attenuati on parameter for identification and grading of nonalcoholic fatty liver disease in adolescents with obesity[J]. Indian J Pediatr, 2022, 89(1): 52-58.
23
曾凡森, 杨花梅, 龚余, 等. 瞬时弹性成像对肥胖儿童肝脏特征的评估价值[J]. 中华医学杂志, 2020, 100(40): 3164-3168.
24
Ferraioli G, Maiocchi L, Raciti MV, et al. Detection of liver steatosis with a novel ultrasound-based technique: a pilot study using MRI-Derived proton density fat fraction as the gold standard[J]. Clin Transl Gastroenterol, 2019, 10(10): e00081.
25
Huang YL, Bian H, Zhu YL, et al. Quantitative diagnosis of nonalcoholic fatty liver disease with ultrasound attenuation imaging in a biopsy-proven cohort[J]. Acad Radiol, 2023, 30(Suppl 1): S155-S163.
26
Dioguardi Burgio M, Castera L, Oufighou M, et al. Prospective comparison of attenuation imaging and controlled attenuation parameter for liver steatosis diagnosis in patients with nonalcoholic fatty liver disease and type 2 diabetes[J].Clin Gastroenterol Hepatol, 2024, 22(5): 1005-1013.e27.
27
Bulakci M, Ercan CC, Karapinar E, et al. Quantitative evaluation of hepatic steatosis using attenuation imaging in a pediatric population: a prospective study[J]. Pediatr Radiol, 2023, 53(8): 1629-1639.
28
赵静, 沈志云, 王慧, 等. 声衰减成像对肥胖儿童非酒精性脂肪性肝病的诊断价值研究[J]. 肿瘤影像学, 2024, 33(2): 163-169.
29
王艳, 李娟, 张敏, 等. 声衰减成像对肥胖儿童非酒精性脂肪性肝病的诊断价值[J]. 中国超声医学杂志, 2025, 41(6): 691-694.
30
Kuroda H, Abe T, Fujiwara Y, et al. Diagnostic accuracy of ultrasound-guided attenuation parameter as a noninvasive test for steatosis in non-alcoholic fatty liver disease[J].J Med Ultrason(2001), 2021, 48(4): 471-480.
31
Kang KA, Lee SR, Jun DW, et al. Diagnostic performance of a novel ultrasound-based quantitative method to assess liver steatosis in histologically identified nonalcoholic fatty liver disease[J]. Med Ultrason, 2023, 25(1): 7-13.
32
刘婷婷, 林妍冰, 汪珊, 等. 超声衰减参数成像评价儿童代谢相关脂肪性肝病的价值[J/OL]. 中华医学超声杂志(电子版), 2023, 20(8): 787-794.
33
Imajo K, Toyoda H, Yasuda S, et al. Utility of ultrasound-guided attenuation parameter for grading steatosis with reference to MRI-PDFF in a large cohort[J]. Clin Gastroenterol Hepatol, 2022, 20(11): 2533-2541.e7.
34
Zhao Y, Jia M, Zhang C, et al. Reproducibility of ultrasound-guided at tenuation parameter (UGAP) to the noninvasive evaluation of hepatic steatosis[J]. Sci Rep, 2022, 12(1): 2876.
35
Zhou Z, Gao A, Zhang Q, et al. Ultrasound backscatter envelope statistics parametric imaging for liver fibrosis characterization: A review[J]. Ultrason Imaging, 2020, 42(2): 92-109.
36
Zhou Z, Zhang Q, Wu W, et al. Hepatic steatosis assessment using quantitative ultrasound parametric imaging based on backscatter envelope statistics[J]. Apply Sci, 2019, 9(4): 661.
37
Chuang YH, Hsieh CS, Lai MW, et al. Detection of pediatric hepatic steatosis through ultrasound back scattering analysis[J].Eur Radiol, 2021, 31(5): 3216-3225.
38
Zhou Z, Gao A, Wu W, et al. Parameter estimation of the homodyned K distribution based on an artificial neural network for ultrasound tissue characterization[J].Ultrasonics, 2021, 111: 106308.
39
Zalcman M, Barth RA, Rubesova E. Real-time ultrasound-derived fat fraction in pediatric population: feasibility validation with MR-PDFF[J].Pediatr Radiol, 2023, 53(12): 2466-2475.
40
Dillman JR, Thapaliya S, Tkach JA, et al. Quantification of hepatic steatosis by ultrasound: prospective comparison to MRI proton-density fat fraction as reference standard[J]. AJR Am J Roentgenol, 2022, 219(5): 784-791.
No related articles found!
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?